Direkt zum Inhalt
Merck
  • 2-Deoxystreptamine-containing aminoglycoside antibiotics: recent advances in the characterization and manipulation of their biosynthetic pathways.

2-Deoxystreptamine-containing aminoglycoside antibiotics: recent advances in the characterization and manipulation of their biosynthetic pathways.

Natural product reports (2012-11-28)
Sung Ryeol Park, Je Won Park, Yeon Hee Ban, Jae Kyung Sohng, Yeo Joon Yoon
ZUSAMMENFASSUNG

The 2-deoxystreptamine-containing aminoglycosides, such as neomycin, kanamycin and gentamicin, are an important class of antibiotics. A detailed understanding of the complete biosynthetic pathway of aminoglycosides and their biosynthetic enzymes will allow us to not only generate more robust antibiotic agents or drugs with other altered biological activities, but also to produce clinically important semi-synthetic antibiotics by direct fermentation. This Highlight focuses on recent advances in the characterization of their biosynthetic enzymes and pathway as well as some chemo-enzymatic and metabolic engineering approaches for the biological production of natural, semi-synthetic, and novel aminoglycosides.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Neomycin -trisulfat (Salz) Hydrat, powder
Sigma-Aldrich
Neomycin -trisulfat (Salz) Hydrat, powder, BioReagent, suitable for cell culture
Supelco
Neomycin -trisulfat (Salz) Hydrat, VETRANAL®, analytical standard
Sigma-Aldrich
Neomycin -trisulfat (Salz) Hydrat, suitable for plant cell culture
Sigma-Aldrich
Neomycin -trisulfat (Salz) Hydrat, meets USP testing specifications, powder
Neomycin-Sulfat, European Pharmacopoeia (EP) Reference Standard